» Articles » PMID: 3560639

Plasma and Urinary Catecholamines As Related to Renal Function in Man

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 1987 Jan 1
PMID 3560639
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

To assess the relationship between renal plasma flow (ERPF) or glomerular filtration rate (GFR) and the levels of norepinephrine (NE) or epinephrine (E) in plasma or urine in the presence of progressive degrees of non-oliguric renal functional impairment, these variables were assessed simultaneously in 18 normal subjects, 72 with parenchymal kidney disease and 14 with essential hypertension. ERPF and GFR were lower (P less than 0.01 to 0.001) in the groups with renal disease (mean +/- SD, 340 +/- 230 and 68 +/- 43 ml/min/1.73 m2, respectively) or essential hypertension (434 +/- 101 and 97 +/- 25 ml/min/1.73 m2) than normal subjects (597 +/- 133 and 118 +/- 14 ml/min/1.73 m2). Plasma and urinary NE and E did not differ significantly among groups and were unrelated with ERPF or GFR (range 4 to 160 ml/min/1.73 m2), except for reduced (P less than 0.001) urinary NE and E excretion in the presence of a GFR less than 20 ml/min. Subgroups with renal disease and a normal (N = 39) or high blood pressure (N = 33) also were comparable in their plasma and urinary NE and E, while ERPF and GFR tended to be lower in hypertensive patients. It is concluded that a chronic reduction in excretory kidney function may have no relevant impact on circulating levels of NE and E per se, although their urinary excretion falls distinctly at the stage of advanced renal failure. These aspects deserve consideration when pathogenetic or diagnostic studies of catecholamines are performed in normotensive or hypertensive patients with impaired kidney function.

Citing Articles

Optimized procedures for testing plasma metanephrines in patients on hemodialysis.

Pamporaki C, Prejbisz A, Malecki R, Pistrosch F, Peitzsch M, Bishoff S Sci Rep. 2021; 11(1):14706.

PMID: 34282182 PMC: 8290036. DOI: 10.1038/s41598-021-94104-9.


Effects of Pulmonary Hypertension and Right Ventricular Function in Short and Long-Term Kidney Function.

Naranjo M, Lo K, Mezue K, Rangaswami J Curr Cardiol Rev. 2018; 15(1):3-11.

PMID: 30306876 PMC: 6367698. DOI: 10.2174/1573403X14666181008154215.


Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly.

Toba H, Lindsey M Pharmacol Ther. 2018; 193:99-120.

PMID: 30149103 PMC: 6309764. DOI: 10.1016/j.pharmthera.2018.08.014.


Management of cardiorenal metabolic syndrome in diabetes mellitus: a phytotherapeutic perspective.

Song M, Davies N, Roufogalis B, Huang T J Diabetes Res. 2014; 2014:313718.

PMID: 24818164 PMC: 4003752. DOI: 10.1155/2014/313718.


Effects of CPAP on nitrate and norepinephrine levels in severe and mild-moderate sleep apnea.

Pinto P, Barbara C, Montserrat J, Patarrao R, Guarino M, Carmo M BMC Pulm Med. 2013; 13:13.

PMID: 23497046 PMC: 3602188. DOI: 10.1186/1471-2466-13-13.